Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Leukemia

Free Subscription 08.06.2026 2 Am J Hematol 1 Ann Hematol 3 Blood 3 BMC Cancer 1 Bone Marrow Transplant 1 Cancer Lett 1 Cancer Res 3 Leuk Lymphoma 1 Leuk Res 2 Leukemia 3 N Engl J Med 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. PACKARD DG, Kumar SK, Dispenzieri A, Kapoor P, et al
   Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia.
   Am J Hematol. 2026 Jun 3. doi: 10.1002/ajh.70400.
   PubMed         Abstract available
   
   
2. ASPAS REQUENA G, Rodriguez-Veiga R, Gil C, Botella C, et al
   Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.
   Am J Hematol. 2026;101:1692-1705.
   PubMed         Abstract available
   
   

   
   Ann Hematol

3. YUKSEL S, Aygun RS, Yuksel M, Oruncu MB, et al
   IGHV mutational status and BCR stereotypy in chronic lymphocytic leukemia: A Turkish cohort analysis.
   Ann Hematol. 2026 Jun 3. doi: 10.1007/s00277-026-07096.
   PubMed         Abstract available
   
   

   
   Blood

4. HOURIGAN CS, Beugelink L, Othman J, Gui G, et al
   ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid Leukemia.
   Blood. 2026 Jun 3:blood.2026033569. doi: 10.1182/blood.2026033569.
   PubMed         Abstract available
   
   
5. PASUPULETI SK, Ramdas B, Padam KSR, Kanumuri R, et al
   Therapeutic Targeting of IL-17A-Driven PTGS2/NLRP3 Inflammasome Activation in Juvenile Myelomonocytic Leukemia.
   Blood. 2026 Jun 2:blood.2025032588. doi: 10.1182/blood.2025032588.
   PubMed         Abstract available
   
   
6. WANG ES, Erba HP, Zeidan AM, Roboz GJ, et al
   Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia.
   Blood. 2026 Jun 2:blood.2026034043. doi: 10.1182/blood.2026034043.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. CHUA YW, Chow SC
   Simultaneous activation and late-stage inhibition of autophagy induces autophagy-dependent cell death in leukemia.
   BMC Cancer. 2026 Jun 4. doi: 10.1186/s12885-026-16102.
   PubMed         Abstract available
   
   
8. SHAYANMANESH M, Ahmadi SE, Faranoush M, Safa M, et al
   Expression patterns of GPX4 and LINC00618 across disease phases in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): an exploratory study.
   BMC Cancer. 2026 Jun 4. doi: 10.1186/s12885-026-16296.
   PubMed         Abstract available
   
   
9. HUANG Y, Long Z, Zhang Y, Cheng J, et al
   Impact of RUNX1 mutations at distinct sites on the clinical characteristics and prognosis of patients with acute myeloid leukemia.
   BMC Cancer. 2026 Jun 3. doi: 10.1186/s12885-026-16238.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

10. WU C, Xue L, Wu M, Li S, et al
    Non-gene-edited, CD19-targeted, allogeneic CAR-T cell therapy for relapsed or refractory B-cell acute lymphoblastic leukemia: an open-label, single-arm phase 1 study.
    Bone Marrow Transplant. 2026 Jun 4. doi: 10.1038/s41409-026-02929.
    PubMed         Abstract available
    
    

    
    Cancer Lett

11. WANG JD, Liao CJ, Lei XX, Peng ZZ, et al
    NPM1 mutation promotes creatine anabolism by FTO-dependent m(6)A demethylation to drive macrophage M2 polarization in acute myeloid leukemia.
    Cancer Lett. 2026 May 29:218637. doi: 10.1016/j.canlet.2026.218637.
    PubMed         Abstract available
    
    

    
    Cancer Res

12. ALLSUP DJ, Kamiguti AS, Lin K, Sherrington PD, et al
    Editor's Note: B-Cell Receptor Translocation to Lipid Rafts and Associated Signaling Differ Between Prognostically Important Subgroups of Chronic Lymphocytic Leukemia.
    Cancer Res. 2026;86:2823.
    PubMed        
    
    

    
    Leuk Lymphoma

13. TADMOR T, Levy Yurkovski I, Kreiniz N, Gorenberg M, et al
    FDG PET-CT in hairy cell leukemia: defining standard metabolic uptake across disease compartments.
    Leuk Lymphoma. 2026 Jun 3:1-4. doi: 10.1080/10428194.2026.2682291.
    PubMed        
    
    
14. GOTETI S, Kim MS, Cai J, Hayes-Lattin B, et al
    Lineage switch from T- ALL to a clonal related T/myeloid leukemia following treatment with CD38 directed therapy.
    Leuk Lymphoma. 2026 Jun 1:1-4. doi: 10.1080/10428194.2026.2654779.
    PubMed        
    
    
15. HORSCH L, Baron J, Sung PJ, Wang ES, et al
    Management and risk mitigation strategies for FLT3-ITD+ acute myeloid leukemia: clinical utilization of quizartinib.
    Leuk Lymphoma. 2026 May 30:1-8. doi: 10.1080/10428194.2026.2676107.
    PubMed         Abstract available
    
    

    
    Leuk Res

16. FAVRIN G, Cappello E, Rattotti S, Picone C, et al
    Regression of T-LGL leukemia in a patient treated with sildenafil for pulmonary hypertension.
    Leuk Res. 2026;167:108257.
    PubMed        
    
    

    
    Leukemia

17. LI AM, Aftandilian C, Annesley C, Colace S, et al
    Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemia.
    Leukemia. 2026 Jun 3. doi: 10.1038/s41375-026-02997.
    PubMed        
    
    
18. CHATTERJEE A, Mustafa Ali MK, Bailey CM, Liu Y, et al
    Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitors.
    Leukemia. 2026 Jun 2. doi: 10.1038/s41375-026-02982.
    PubMed         Abstract available
    
    

    
    N Engl J Med

19. ANNAMALAY A, Radich J
    Chronic Myeloid Leukemia in Low- and Middle-Income Countries. Reply.
    N Engl J Med. 2026;394:2175-2176.
    PubMed        
    
    
20. MAHON FX, Rea D, Rousselot P
    Chronic Myeloid Leukemia in Low- and Middle-Income Countries.
    N Engl J Med. 2026;394:2175.
    PubMed        
    
    
21. ROBOZ GJ, Zeidan AM, Mannis GN, Montesinos P, et al
    All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia.
    N Engl J Med. 2026;394:2107-2116.
    PubMed         Abstract available
    
    

    
    PLoS One

22. LIU P, Xu Z, Song W, Yang J, et al
    Burden of acute lymphoblastic leukemia in children and adolescents in low- and middle-income countries from 1990 to 2023 and projections to 2050: A systematic analysis from the global burden of disease study 2023.
    PLoS One. 2026;21:e0350223.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum